Back to all DocMorris AG press releases

DocMorris AG

  • SIX:DOCM

DocMorris reports Q1 2026 growth and confirms EBITDA break-even expectation

Published

Get alerts

Plain English summaries when DocMorris AG announces news.

At a glance

Company
DocMorris AG
Listings
SIX:DOCM
Announcement type
Trading update
Published
Reporting period
first quarter of 2026
Source announcement
eqs-news.com
Key figures
Measure Figure Period Compared with
External revenue CHF 318.1 million the first quarter of 2026 Not stated
Revenue CHF 303.8 million the first quarter of 2026 Not stated
Adjusted EBITDA minus CHF 6.3 million the first quarter of 2026 minus CHF 16.1 million in the previous year (an improvement of CHF 9.8 million)

Figures are quoted from this announcement and selected automatically.

FAQSIR Generated from this announcement View original release below for safe harbor and regulatory notices

Announcement Summary

DocMorris AG (ticker DOCM) reported first-quarter 2026 results, with revenue growth and management’s 2026 break-even expectations.

  • External revenue increased 10.7 per cent in local currency to CHF 318.1 million; revenue rose 11.7 per cent to CHF 303.8 million.
  • External Rx revenue rose 30.4 per cent; sequential Rx growth was 7.6 per cent, while Non-Rx increased 6.5 per cent.
  • Adjusted EBITDA was minus CHF 6.3 million; management reported a CHF 9.8 million improvement, and prior-year adjusted EBITDA was minus CHF 16.1 million.
  • Management confirmed 2026 expectations, including EBITDA break-even during 2026 and free cash flow break-even during 2027.
  • Digital Services revenue growth was 63.1 per cent, including TeleClinic, retail media and marketplace.

Percentages are in local currency. Active customers rose year-on-year by 1.0 million to 12.6 million; 0.4 million were added in Q1 2026. A conference call will be held today at 11 a.m. in English.

Investor FAQs

DocMorris reported its first-quarter 2026 results, including external revenue growth of 10.7 per cent to CHF 318.1 million and adjusted EBITDA of minus CHF 6.3 million. The company also said it remains on plan to reach EBITDA break-even during 2026.

Source announcement

Company
DocMorris AG
Title
DocMorris achieves strong revenue growth in Q1 2026 – on track for EBITDA break-even
Published
Source site
eqs-news.com

Read the source announcement on eqs-news.com

FAQSIR's summary and investor FAQs are generated by AI from the text of this announcement alone, without information from other sources.

Figures, forecasts and other claims are the announcement's, not FAQSIR's. FAQSIR does not independently verify them.

Read the original press release

Full text as published, unedited.

Loading the original release…